SHAIK UBAID: Open Payments
NPI 1720023880 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 67 payments from 18 companies in 2025. Trend: 2023 $1,697 · 2024 $1,277 · 2025 $1,679
Food & beverage: $1,679
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 10 | $312 |
| ARGENX US, INC. | 4 | $180 |
| Eisai Inc. | 6 | $145 |
| Vanda Pharmaceuticals Inc. | 6 | $141 |
| EMD Serono, Inc. | 4 | $121 |
| Lilly USA, LLC | 6 | $116 |
| UCB, Inc. | 5 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $95 |
| ABBVIE INC. | 4 | $94 |
| Alexion Pharmaceuticals, Inc. | 3 | $79 |
Products named: Leqembi, PONVORY, VYVGART, XCOPRI, KISUNLA, INGREZZA, UBRELVY, ULTOMIRIS.
Industry payments across NY — which companies pay providers there.
